L1 Capital Global Opportunities Master Fund, Ltd. 13D and 13G filings for Sunshine Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-22 4:10 pm Purchase | 2026-05-18 | 13G | SUNSHINE BIOPHARMA INC PAR SBFM | L1 Capital Global Opportunities Master Fund, Ltd. | 100,000 5.830% | 85,776 (+603.04%) | Filing |